DE3620813A1
(de)
*
|
1986-06-21 |
1987-12-23 |
Boehringer Ingelheim Kg |
Neue tetrahydro-benzothiazole, ihre herstellung und verwendung
|
US4826860A
(en)
*
|
1987-03-16 |
1989-05-02 |
Warner-Lambert Company |
Substituted 2-aminobenzothiazoles and derivatives useful as cerebrovascular agents
|
US4988699A
(en)
*
|
1989-03-14 |
1991-01-29 |
Warner-Lambert Company |
Substituted tetrahydrobenzothiazoles as dopaminergic agents
|
DE3923689A1
(de)
*
|
1989-07-18 |
1991-01-24 |
Boehringer Ingelheim Kg |
Neue verwendung von tetrahydrobenzthiazolderivaten als arzneistoffe
|
DE3930282A1
(de)
*
|
1989-09-11 |
1991-03-21 |
Boehringer Ingelheim Kg |
Verwendung von dopamin-autorezeptor-agonisten bei der behandlung von drogenabhaengigkeit
|
DE3937271A1
(de)
*
|
1989-11-09 |
1991-05-16 |
Boehringer Ingelheim Kg |
Transdermale applikation von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol
|
FR2674853B1
(fr)
*
|
1991-04-03 |
1995-01-20 |
Synthelabo |
Derives de piperidinylguanidine, leur preparation et leur application en therapeutique.
|
DE4241013A1
(de)
|
1992-12-05 |
1994-06-09 |
Boehringer Ingelheim Kg |
Verwendung von 2-Amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol als Arzneimittel mit antidepressiver Wirkung
|
US6156777A
(en)
*
|
1994-12-15 |
2000-12-05 |
Pharmacia & Upjohn Company |
Use of pramipexole as a neuroprotective agent
|
US5650420A
(en)
*
|
1994-12-15 |
1997-07-22 |
Pharmacia & Upjohn Company |
Pramipexole as a neuroprotective agent
|
DE19507752A1
(de)
*
|
1995-03-06 |
1996-09-12 |
Bayer Ag |
Verfahren zur Herstellung von substituierten Cyclohexanonen
|
DE19536916A1
(de)
*
|
1995-10-04 |
1997-04-10 |
Boehringer Ingelheim Kg |
Inhalative Applikation von 2-Amino-6n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol, insbesondere seines (-)-Enantiomeren, sowie deren pharmakologisch verträgliche Säureadditionssalze
|
CZ370198A3
(cs)
*
|
1996-05-31 |
1999-05-12 |
Pharmacia & Upjohn Company |
Aryl substituované cyklické aminy jako selektivní dopaminové D3 ligandy
|
US6001861A
(en)
|
1998-01-16 |
1999-12-14 |
Pharmacia & Upjohn Company |
Use of pramipexole in the treatment of restless legs syndrome
|
DE19701619B4
(de)
*
|
1997-01-17 |
2007-10-11 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Verwendung von Pramipexol zur Behandlung des restless legs syndroms
|
AU760439B2
(en)
*
|
1998-05-15 |
2003-05-15 |
Pharmacia & Upjohn Company |
Cabergoline and pramipexole: new uses and combinations
|
SE9802360D0
(sv)
|
1998-07-01 |
1998-07-01 |
Wikstroem Hakan Vilhelm |
New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins ((basic)-N-substituted and (basic)-N,N-disubstituted derivatives of 2,6-diamino-thiazolo(4,5-f)indan and 2,7-di-amino-thiazolo(4,5-g)tetralin
|
DE19830201A1
(de)
*
|
1998-07-07 |
2000-01-13 |
Boehringer Ingelheim Pharma |
Mittel mit antidepressiver Wirkung
|
US6232326B1
(en)
|
1998-07-14 |
2001-05-15 |
Jodi A. Nelson |
Treatment for schizophrenia and other dopamine system dysfunctions
|
PE20011074A1
(es)
|
2000-02-23 |
2001-10-04 |
Upjohn Co |
Uso de pramipexol en el tratamiento de trastornos de adiccion
|
CA2415815A1
(fr)
*
|
2000-07-06 |
2002-01-17 |
Nigel H. Greig |
Agents neuroprotecteurs a base d'analogues de tetrahydrobenzothiazole
|
US6277875B1
(en)
|
2000-07-17 |
2001-08-21 |
Andrew J. Holman |
Use of dopamine D2/D3 receptor agonists to treat fibromyalgia
|
US20030114410A1
(en)
|
2000-08-08 |
2003-06-19 |
Technion Research And Development Foundation Ltd. |
Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
|
DE10041478A1
(de)
*
|
2000-08-24 |
2002-03-14 |
Sanol Arznei Schwarz Gmbh |
Neue pharmazeutische Zusammensetzung
|
ES2187249B1
(es)
|
2000-09-18 |
2004-09-16 |
Synthon Bv |
Procedimiento para la preparacion de 2-amino-6-(alquil)amino-4,5,6,7-tetrahidrobenzotiazoles.
|
US20020165246A1
(en)
*
|
2001-03-05 |
2002-11-07 |
Andrew Holman |
Administration of sleep restorative agents
|
DE10137453A1
(de)
*
|
2001-08-02 |
2003-02-20 |
Boehringer Ingelheim Pharma |
Pramlpexol als Antikonvulsivum
|
DE10138275A1
(de)
*
|
2001-08-10 |
2003-02-27 |
Boehringer Ingelheim Pharma |
Verbindungen zur Beseitigung der Anhedonie
|
US20060281797A1
(en)
*
|
2001-12-11 |
2006-12-14 |
University Of Virginia Patent Foundation |
Neurorestoration with R(+) Pramipexole
|
EP2305253A1
(fr)
|
2001-12-11 |
2011-04-06 |
University Of Virginia Patent Foundation |
Utilisation de pramipexole pour traiter la sclérose latérale amyotrophique
|
US20030166696A1
(en)
*
|
2002-01-24 |
2003-09-04 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pramipexole for the treatment of HIV dementia
|
EP2266590A3
(fr)
|
2002-02-22 |
2011-04-20 |
Shire LLC |
Système d'administration de substances actives et méthodes de protection et d'administration de substances actives
|
MY142204A
(en)
*
|
2002-07-25 |
2010-10-29 |
Pharmacia Corp |
Pramipexole once-daily dosage form
|
MY136318A
(en)
*
|
2002-07-25 |
2008-09-30 |
Pharmacia Corp |
Sustained-release tablet composition
|
US20050226926A1
(en)
*
|
2002-07-25 |
2005-10-13 |
Pfizer Inc |
Sustained-release tablet composition of pramipexole
|
GB2394951A
(en)
*
|
2002-11-04 |
2004-05-12 |
Cipla Ltd |
One pot synthesis of 2,6-diamino-4,5,6,7-tetrahydro-benzothiazole
|
US7365086B2
(en)
*
|
2003-07-25 |
2008-04-29 |
Synthon Ip Inc. |
Pramipexole acid addition salts
|
DE102004006808A1
(de)
|
2004-02-11 |
2005-09-01 |
Grünenthal GmbH |
Substituierte 4,5,6,7-Tetrahydro-benzothiazol-2-ylamin-Verbindungen
|
CA2560128A1
(fr)
|
2004-03-19 |
2005-10-06 |
Dipharma S.P.A. |
Intermediaires pour la preparation de pramipexole
|
ES2245604B1
(es)
|
2004-06-25 |
2006-12-01 |
Ragactives, S. L. |
Procedimiento para la obtencion de 2-amino-6-alquil-amino-4,5,6,7-tetrahidrobenzotiazoles.
|
WO2006012276A1
(fr)
*
|
2004-06-30 |
2006-02-02 |
Amr Technology, Inc. |
Processus pour préparer des 2-amino-6-(alkyl)amino-4,5,6,7-tétrahydrobenzothiazoles chiralement purs par résolution chromatographique en phase liquide
|
CA2553311A1
(fr)
*
|
2004-07-01 |
2006-01-12 |
Alembic Limited |
Procede ameliore de preparation d'un derive de tetrahydrobenzothiazole biologiquement actif
|
WO2006003471A2
(fr)
*
|
2004-07-03 |
2006-01-12 |
Generics [Uk] Limited |
Nouveau procede
|
EP2431026A1
(fr)
*
|
2004-08-13 |
2012-03-21 |
Boehringer Ingelheim International GmbH |
Formulation de pastille à libération prolongée contenant du pramipexole ou l'un de ses sels pharmaceutiquement acceptable, son procédé de fabrication et utilisation associée
|
BRPI0513846A
(pt)
|
2004-08-13 |
2008-05-20 |
Boehringer Ingelheim Int |
formulação de comprimido de liberação prolongada contendo pramipexol ou um sal farmaceuticamente aceitável do mesmo, método para a fabricação do mesmo e o uso do mesmo
|
CA2579279C
(fr)
*
|
2004-10-07 |
2013-10-01 |
Boehringer Ingelheim International Gmbh |
Derives de thiazole tricyclique en tant que pi3-kinases
|
ES2310146B1
(es)
*
|
2004-12-30 |
2009-11-11 |
Chemagis Ltd. |
Nuevo procedimiento para preparar pramipexol y su mezcla isomerica optica mediante reduccion con triacetoxiborohidruro de sodio.
|
CN1834092B
(zh)
*
|
2005-03-15 |
2010-04-28 |
姜能桥 |
盐酸普拉克索的制备方法
|
US20090062549A1
(en)
*
|
2005-05-03 |
2009-03-05 |
Seema Kanwar |
Process for the preparation of pramipexole and new anhydrous forms of its dihydrochloride
|
ES2264378B1
(es)
*
|
2005-05-09 |
2007-11-01 |
Ragactives, S.L. |
Procedimiento para la resolucion de 2-amino-6propilamino-4,5,6,7-tetrahidrobenzotiazol y compuestos intermedios.
|
EP1731514A1
(fr)
|
2005-06-02 |
2006-12-13 |
Sandoz AG |
Méthode de préparation du pramipexole
|
CA2619217A1
(fr)
*
|
2005-08-15 |
2007-02-22 |
University Of Virginia Patent Foundation |
Neurorestauration avec du pramipexole r(+)
|
US7994220B2
(en)
|
2005-09-28 |
2011-08-09 |
Cypress Bioscience, Inc. |
Milnacipran for the long-term treatment of fibromyalgia syndrome
|
US20080262053A1
(en)
*
|
2005-10-18 |
2008-10-23 |
Juergen Reess |
Use of Pramipexole for Treating Moderate to Severe Restless Legs Syndrome (Rls)
|
US20070129329A1
(en)
*
|
2005-12-02 |
2007-06-07 |
Alembic Limited |
Stabilized pharmaceutical composition of pramipexole and method of preparation thereof
|
PL378587A1
(pl)
*
|
2005-12-29 |
2007-07-09 |
Instytut Farmaceutyczny |
Sposób wytwarzania (S)-(-)-2-amino-6-n-propyloamino-4,5,6,7-tetrahydrobenzotiazolu i/lub jego soli
|
ITMI20060044A1
(it)
*
|
2006-01-13 |
2007-07-14 |
Dipharma Spa |
Sintesi di intermedi pr la preparazione di pramipexolo
|
US20090098202A1
(en)
*
|
2006-02-10 |
2009-04-16 |
Boehringer Ingelheim International Gmbh |
Extended Release Formulation
|
WO2007090881A2
(fr)
*
|
2006-02-10 |
2007-08-16 |
Boehringer Ingelheim International Gmbh |
Formulation a liberation modifiee
|
US8017598B2
(en)
|
2006-05-16 |
2011-09-13 |
Knopp Neurosciences, Inc. |
Compositions of R(+) and S(−) pramipexole and methods of using the same
|
US8518926B2
(en)
|
2006-04-10 |
2013-08-27 |
Knopp Neurosciences, Inc. |
Compositions and methods of using (R)-pramipexole
|
US20070259930A1
(en)
*
|
2006-04-10 |
2007-11-08 |
Knopp Neurosciences, Inc. |
Compositions and methods of using r(+) pramipexole
|
EP2497473A1
(fr)
|
2006-05-16 |
2012-09-12 |
Knopp Neurosciences, Inc. |
Quantités thérapeutiquement efficaces de R(+) et S(-) pramipexole pour une utilisation dans le traitement de la maladie de Parkinson et compositions pharmaceutiques correspondantes
|
EP2026766A1
(fr)
|
2006-05-17 |
2009-02-25 |
Synthon B.V. |
Composition en comprimé pour la libération prolongée de la tamsulosine
|
WO2008001200A2
(fr)
*
|
2006-06-29 |
2008-01-03 |
Antares Pharma Ipl Ag |
Composition transdermique à stabilité de couleur améliorée
|
US20080254118A1
(en)
*
|
2007-04-11 |
2008-10-16 |
Hans-Werner Wernersbach |
Process for preparing pramipexole dihydrochloride tablets
|
WO2008041240A1
(fr)
*
|
2006-10-03 |
2008-04-10 |
Cadila Healthcare Limited |
Procédé de préparation de (s)-pramipexole et de ses intermédiaires
|
US8524695B2
(en)
|
2006-12-14 |
2013-09-03 |
Knopp Neurosciences, Inc. |
Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
|
WO2008086353A1
(fr)
*
|
2007-01-08 |
2008-07-17 |
Zurawski Vincent R Jr |
Dérivés contenant du propargyle de tétrahydro-benzthiazoles et procédés de fabrication et d'utilisation de ceux-ci
|
SI22446A
(sl)
*
|
2007-02-07 |
2008-08-31 |
Krka, Tovarna Zdravil, D.D., Novo Mesto |
Nov postopek za sintezo pramipeksola in njegovih farmacevtsko sprejemljivih soli
|
US8519148B2
(en)
|
2007-03-14 |
2013-08-27 |
Knopp Neurosciences, Inc. |
Synthesis of chirally purified substituted benzothiazole diamines
|
US20080254117A1
(en)
*
|
2007-04-10 |
2008-10-16 |
Noel Cotton |
Process for preparing pramipexole dihydrochloride tablets
|
CN105330743B
(zh)
|
2007-08-02 |
2019-05-28 |
吉利德生物制剂公司 |
Lox和loxl2抑制剂及其应用
|
GB0721333D0
(en)
*
|
2007-10-31 |
2007-12-12 |
Motac Neuroscience Ltd |
Medicaments
|
US20090247537A1
(en)
*
|
2008-03-25 |
2009-10-01 |
William Dale Overfield |
Methods for preventing or treating bruxism using dopaminergic agents
|
CN102186350A
(zh)
*
|
2008-08-19 |
2011-09-14 |
诺普神经科学股份有限公司 |
使用(r)-普拉克索的组合物与方法
|
WO2010080769A2
(fr)
|
2009-01-06 |
2010-07-15 |
Arresto Biosciences, Inc. |
Procédés et compositions chimiothérapeutiques
|
BRPI1010084A2
(pt)
*
|
2009-06-19 |
2015-08-25 |
Knopp Neurosciences Inc |
Método para tratar esclerose lateral amiotrófica em um paciente
|
AU2010284039A1
(en)
*
|
2009-08-21 |
2012-03-22 |
Gilead Biologics, Inc. |
In vivo screening assays
|
US20110044907A1
(en)
*
|
2009-08-21 |
2011-02-24 |
Derek Marshall |
In vivo screening assays
|
AU2010284000A1
(en)
*
|
2009-08-21 |
2012-03-22 |
Gilead Biologics, Inc. |
In vitro screening assays
|
BR112012008084A2
(pt)
*
|
2009-08-21 |
2019-09-24 |
Gilead Biologics Inc |
método terapêuticos e composições.
|
JP2013502226A
(ja)
|
2009-08-21 |
2013-01-24 |
ギリアド バイオロジクス,インク. |
リシル酸化酵素及びloxl2由来の触媒ドメイン
|
TR200906997A1
(tr)
|
2009-09-11 |
2011-03-21 |
Sanovel �La� San. Ve T�C. A. �. |
Pramipeksol farmasötik bileşimleri.
|
TR200907554A1
(tr)
|
2009-10-06 |
2011-04-21 |
Sanovel İlaç San.Ve Ti̇c.A.Ş. |
Oral yolla dağılan pramıpexole bileşimleri.
|
EP2525786A2
(fr)
|
2010-01-18 |
2012-11-28 |
Synthon BV |
Comprimés à libération prolongée de pramipexole
|
CN105622757A
(zh)
|
2010-02-04 |
2016-06-01 |
吉联亚生物科技有限公司 |
结合赖氨酰氧化酶样2(loxl2)的抗体和其使用方法
|
US20130079526A1
(en)
|
2010-03-03 |
2013-03-28 |
Knopp Neurosciences Inc. |
Synthesis of Chirally Purified Substituted Benzothiazole Diamines
|
TR201001862A1
(tr)
*
|
2010-03-11 |
2011-10-21 |
Sanovel �La� San.Ve T�C.A.�. |
Kontrollü salım gerçekleştiren pramipeksol formülasyonları.
|
AU2011256928A1
(en)
|
2010-05-24 |
2012-12-20 |
Lupin Limited |
Extended release formulation of pramipexole
|
EP2462925A1
(fr)
|
2010-11-12 |
2012-06-13 |
Neuraxpharm Arzneimittel GmbH |
Granulé de dihydrochlorure de pramipexole
|
TWI537274B
(zh)
|
2011-03-14 |
2016-06-11 |
橘生藥品工業股份有限公司 |
新穎之八氫噻吩并喹啉衍生物、含有其之醫藥組成物及該等之用途
|
WO2012140604A1
(fr)
|
2011-04-15 |
2012-10-18 |
Sandoz Ag |
Formulations stables de chlorhydrate de pramipexole
|
ITMI20110666A1
(it)
*
|
2011-04-19 |
2012-10-20 |
Dipharma Francis Srl |
Procedimento per la preparazione di (r) ed (s) pramipexolo e suoi intermedi
|
WO2013096816A1
(fr)
|
2011-12-22 |
2013-06-27 |
Biogen Idec Ma Inc. |
Synthèse améliorée de composés substitués par amine de 4,5,6,7-tétrahydrobenzothiazole
|
EP2732812A1
(fr)
|
2012-11-15 |
2014-05-21 |
Aristo Pharma GmbH |
Comprimé de pramipexol à libération prolongée
|
WO2014092006A1
(fr)
|
2012-12-10 |
2014-06-19 |
キッセイ薬品工業株式会社 |
Nouveau dérivé d'octahydropyridoquinazoline, composition pharmaceutique le contenant, et utilisations pour ledit dérivé et ladite composition
|
US9662313B2
(en)
|
2013-02-28 |
2017-05-30 |
Knopp Biosciences Llc |
Compositions and methods for treating amyotrophic lateral sclerosis in responders
|
BR112016000627B1
(pt)
|
2013-07-12 |
2022-02-08 |
Knopp Biosciences Llc |
Uso de dexpramipexol ou um sal farmaceuticamente aceitável do mesmo
|
US9468630B2
(en)
|
2013-07-12 |
2016-10-18 |
Knopp Biosciences Llc |
Compositions and methods for treating conditions related to increased eosinophils
|
ES2813674T3
(es)
|
2013-08-13 |
2021-03-24 |
Knopp Biosciences Llc |
Composiciones y métodos para el tratamiento de trastornos de células plasmáticas y trastornos prolinfocíticos de células b
|
HUE055850T2
(hu)
|
2013-08-13 |
2022-01-28 |
Knopp Biosciences Llc |
Készítmények és módszerek a krónikus urticaria (csalánkiütés) kezelésére
|
EP2870965A1
(fr)
|
2013-11-06 |
2015-05-13 |
Sanovel Ilac Sanayi ve Ticaret A.S. |
Formulations pharmaceutiques liquides orales de pramipexole
|
EP2870961B1
(fr)
|
2013-11-06 |
2018-07-18 |
Sanovel Ilac Sanayi ve Ticaret A.S. |
Formulations effervescentes de pramipexole
|
CN103626718A
(zh)
*
|
2013-12-13 |
2014-03-12 |
山东新华制药股份有限公司 |
盐酸普拉克索的工业化制备方法
|
CN103664820B
(zh)
*
|
2013-12-30 |
2016-01-27 |
四川科伦药业股份有限公司 |
普拉克索类似物及其制备方法
|
CN109922796B
(zh)
|
2016-06-23 |
2023-04-07 |
考里安有限责任公司 |
具有亲水和疏水域的粘合剂基质和治疗剂
|
KR102555208B1
(ko)
|
2016-07-27 |
2023-07-17 |
코리움, 엘엘씨 |
아민 약물의 나트륨 바이카보네이트 제자리 전환 구동된 경피성 전달
|
MX2019001104A
(es)
|
2016-07-27 |
2019-10-02 |
Corium Int Inc |
Sistemas de suministro transdermico de memantina.
|
JP7469879B2
(ja)
|
2016-07-27 |
2024-04-17 |
コリウム, エルエルシー |
経口送達と生物学的に同等である薬物動態を有する経皮送達システム
|
CA3059418A1
(fr)
|
2017-04-10 |
2018-10-18 |
Chase Therapeutics Corporation |
Association comprenant un antagoniste de nk1 et methode de traitement de synucleinopathies
|
CA3104811C
(fr)
|
2017-06-30 |
2024-05-28 |
Chase Therapeutics Corporation |
Composition comprenant du pramipexole et des antagonistes nk1 pour traiter la depression
|
WO2019126531A1
(fr)
|
2017-12-20 |
2019-06-27 |
Corium, Inc. |
Composition adhésive transdermique comprenant un agent thérapeutique liquide volatil à bas point de fusion
|
CN110734413A
(zh)
*
|
2019-12-02 |
2020-01-31 |
山东铂源药业有限公司 |
一种普拉克索中间体2,6-二氨基-4,5,6,7-四氢苯并噻唑的制备方法
|
CN111333593B
(zh)
*
|
2020-04-22 |
2022-04-29 |
湖北可赛化工有限公司 |
一种合成4-甲基-2肼基苯并噻唑的方法
|
EP4249476A1
(fr)
*
|
2020-11-19 |
2023-09-27 |
Sichuan Kelun Pharmaceutical Research Institute Co., Ltd. |
Sel de composé benzothiazole, forme cristalline et son utilisation
|